|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 413/14 | |
| A61K 31/5377 | |||
| A61P 7/02 |
| (11) | Number of the document | 2288606 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09761414.3 |
| Date of filing the European patent application | 2009-06-03 | |
| (97) | Date of publication of the European application | 2011-03-02 |
| (45) | Date of publication and mention of the grant of the patent | 2012-02-15 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2009/003952 |
| Date | 2009-06-03 |
| (87) | Number | WO 2009/149851 |
| Date | 2009-12-17 |
| (30) | Number | Date | Country code |
| 102008028071 | 2008-06-12 | DE |
| (72) |
GRUNENBERG, Alfons, DE
FÄHNRICH, Karsten, DE
QUECKENBERG, Olaf, DE
REUTE, Christiane, DE
KEIL, Birgit, DE
GUSHURST, Karen, Sue, US
STILL, Ezra, John, US
|
| (73) |
Bayer Pharma Aktiengesellschaft,
Müllerstrasse 178, 13353 Berlin,
DE
|
| (54) | NEUE COKRISTALL-VERBINDUNG VON RIVAROXABAN UND MALONSÄURE |
| NEW CO-CRYSTAL COMPOUND OF RIVAROXABAN AND MALONIC ACID |